Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tangning Tongluo Capsule is a traditional Chinese medicine formulation developed for the treatment of type 2 diabetes and its complications. It is designed based on principles of traditional Chinese medicine (TCM) and has been evaluated in clinical trials for efficacy and safety in patients with type 2 diabetes. The mechanism of action is not fully elucidated but, as a TCM product, it likely involves multiple herbal components acting synergistically to regulate blood glucose levels and improve metabolic function. The drug has undergone clinical studies to determine optimal dosage and assess its impact on glycemic control in diabetic patients[3][4][1]. Tangning Tongluo Capsule was developed by Guizhou Bailing Group Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tangning Tongluo Capsule.